Stockchase Opinions

Jim Cramer - Mad MoneyTilray Inc.TLRYWATCHApr 05, 2024

Florida's upcoming vote to legalize cannabis could impact the industry. So, he will go back to this name after a long call and listen to their conference call.

$2.59

Stock price when the opinion was issued

0
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

You might be interested:

DON'T BUY

Even with talk of rescheduling cannabis, US names offer significantly more upside than Canadian names. Look to the US if you want to take on this risk. If you own this one, use it as a tax loss.

premiumPremium content

🔒 Premium Content Alert – This buzzing stock opinion is accessible only to Stockchase Premium

Discover an exclusive list and analysis of the stocks that are trending on social medias—accessible only to our Premium subscribers. With a keen focus on the stocks that are setting social media ablaze, this weekly feature offers an invaluable lens through which to evaluate market movers. Say goodbye to the endless scroll through social media timelines; we curate the buzz so you can invest your time as wisely as your money. Unlock Premium Now.

TOP PICK

Tilray reported a revenue of 288M, which is a -6.6% change from the previous quarter. An increase in revenue typically indicates growing demand for the company's products or services. A decline in revenue can be concerning, as it might indicate reduced sales or challenges in the market. It's important to investigate further to understand the underlying causes. Gross Profit stood at 79M, marking a -14.9% change since the last quarter. Gross profit showcases the efficiency in production and sales processes. Social media mentions are up 28.2% in the past 24h.

premiumPremium content

🔒 Premium Content Alert – This buzzing stock opinion is accessible only to Stockchase Premium

Discover an exclusive list and analysis of the stocks that are trending on social medias—accessible only to our Premium subscribers. With a keen focus on the stocks that are setting social media ablaze, this weekly feature offers an invaluable lens through which to evaluate market movers. Say goodbye to the endless scroll through social media timelines; we curate the buzz so you can invest your time as wisely as your money. Unlock Premium Now.

TOP PICK

Tilray reported a revenue of 210M, which is a -32% change from the previous quarter. An increase in revenue typically indicates growing demand for the company's products or services. A decline in revenue can be concerning, as it might indicate reduced sales or challenges in the market. It's important to investigate further to understand the underlying causes.Gross Profit stood at 57M, marking a -38.1% change since the last quarter. Gross profit showcases the efficiency in production and sales processes. Social media mentions are up 24.9% in the past 24h.

DON'T BUY

A lot of $$ was made, but now investors have come to realize marijuana is just a commodity. The company bears all the costs, but it has the federal/provincial government as a partner that shares equally in all the upside, but none of the down. Even advertising is restricted.

For a consumer stock, he holds Unilever.

DON'T BUY

Avoid the sector. High risk, speculative. Doesn't see catalysts to drive the sector higher, especially if Republicans succeed in the US election.

WATCH

So much wealth got destroyed in the cannabis sector, but Tilray will be one of the survivors. He can't offer a solid opinion about TLRY, because he needs to learn more about it, but he's starting to study the cannabis sector. Something will happen in the U.S. that will make banking for these companies allowable--and this will be a major move.

BUY ON WEAKNESS

Bottoming process a good place to buy for investors. Would wait a bit before investing. Not much momentum in company. 

WATCH

Are diversifying away from cannabis into alcohol which diversifies their revenues. They bought Hexo. Interesting company. Also, they hold a lot of cash which will allow them buying more companies. 

DON'T BUY

In past years, executives were lavishly compensated. He owns no cannabis stocks. Have been hopes that the Democrats will decriminalize cannabis and is unlikely to happen. So, these businesses are stuck in no-man's land. For instance, they can't deduct rent from expenses, or can't get bank loans.

DON'T BUY

Remember, it's a small cap so can be volatile. In the past two months, it's failing to break out. He's cool towards it.

DON'T BUY

Too speculative and it's losing money.

SELL

Death spiral. The hype was crazy. None of these companies is going to make any money. Sell it, take the loss, move on. No chance for a rebound. 

BUY
A smart move to get into beer by buying some brands. True, they are losing money, but this and Canopy are the best in this space.
COMMENT
It reports Friday. He expects them to make a bold announcement about the U.S. legalization of cannabis. Shares are so low. For once, this could be a decent spec buy.